ロード中...

Prevention of COPD exacerbation by lysozyme: a double-blind, randomized, placebo-controlled study

BACKGROUND/AIM: Lysozyme (mucopeptide N-acetyl-muramyl hydrolase) is widely used as a mucolytic and anti-inflammatory agent in Japan. We evaluated the effects of long-term lysozyme administration on COPD exacerbation. METHODS: In a 1-year, randomized, double-blind, placebo-controlled, parallel trial...

詳細記述

保存先:
書誌詳細
出版年:Int J Chron Obstruct Pulmon Dis
主要な著者: Fukuchi, Yoshinosuke, Tatsumi, Koichiro, Inoue, Hiromasa, Sakata, Yukinori, Shibata, Kai, Miyagishi, Hideaki, Marukawa, Yasuhiro, Ichinose, Masakazu
フォーマット: Artigo
言語:Inglês
出版事項: Dove Medical Press 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4846053/
https://ncbi.nlm.nih.gov/pubmed/27143873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S103105
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!